Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Current HIV/AIDS Reports
Metadata
Title
Use of pharmacy refill data as a measure of antiretroviral adherence
Authors
Robert Grossberg
Robert Gross
Publication date
01-11-2007
Publisher
Current Science Inc.
Published in
Current HIV/AIDS Reports / Issue 4/2007
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-007-0027-4

Other articles of this Issue 4/2007

Current HIV/AIDS Reports 4/2007 Go to the issue

OriginalPaper

Poverty, unstable housing, and HIV infection among women living in the United States

OriginalPaper

Risk compensation in HIV prevention: Implications for vaccines, microbicides, and other biomedical HIV prevention technologies

OriginalPaper

The role of safer injection facilities in the response to HIV/AIDS among injection drug users

OriginalPaper

Current trends in internet-and cell phone-based HIV prevention and intervention programs

OriginalPaper

Private sector provision and financing of AIDS treatment in Africa: Current developments

OriginalPaper

Emerging HIV epidemics in muslim countries: Assessment of different cultural responses to harm reduction and implications for HIV control

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits